Testosterone acetate
| Clinical data | |
|---|---|
| Trade names | Aceto-Sterandryl, Aceto-Testoviron, Amolisin, Androtest A, Deposteron, Farmatest, Perandrone A | 
| Other names | Testosterone ethanoate; Testosterone 17β-acetate; Androst-4-en-17β-ol-3-one 17β-acetate | 
| Routes of administration | Intramuscular injection | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.012.615 | 
| Chemical and physical data | |
| Formula | C21H30O3 | 
| Molar mass | 330.468 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
Testosterone acetate (brand names Aceto-Sterandryl, Aceto-Testoviron, Amolisin, Androtest A, Deposteron, Farmatest, Perandrone A), or testosterone ethanoate, also known as androst-4-en-17β-ol-3-one 17β-acetate, is an androgen and anabolic steroid and a testosterone ester. The drug was first described in 1936 and was one of the first androgen esters and esters of testosterone to be synthesized.